Infectious Disease Diagnostics Market, 2019-2023: Supplier Shares by Country and Strategic Assessments of Leading Suppliers
This 155-page report provides detailed analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics, biochips, monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scattering, chromatography and several others.
The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Contains 155 pages
Current and Emerging Technologies
Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
0 Polymerase Chain Reaction
- Temperature Cyclers
- PCR Variations
0 Immuno-PCR
0 QC-PCR
0 DAP-PCR
0 Ligase Chain Reaction
0 Branched DNA
0 Q-Beta Replicase
0 Nucleic-Acid Sequence-Based
0 Strand Displacement Activation
Monoclonal Antibodies
Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
0 Overview
0 ELISA
0 Dot Immunobinding Assays
0 Capillary Immunoassays
0 Particle-Membrane Capture Immunoassays
0 Enzyme Amplification
c. Fluorescent Immunoassays
0 Fluorescence Polarization
0 Time-Resolved Pulse Fluorescence
d. Luminescence
0 Chemiluminescence
0 Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
Differential Light Scattering
IT
Artificial Intelligence
Liposomes
Flow Cytometry
Chromatography
MRI
Gel Microdroplets
Other
Competitive Profiles
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical *6.
- Kreatech /HLFD
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac 3(
- Wako
Global AI-Enabled Drug Discovery and Clinical Trials Market by Component (Solutions and Services), By Solution (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases, Immunologic Diseases, Infectious Diseases and Others), By End-User(Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast to 2020 to 2027
Global AI-Enabled Drug Discovery and Clinical Trials Market by Component (Solutions and Services), By Solution (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases, Immunologic Diseases, Infectious Diseases and Others), By End-User(Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast to 2020 to 2027 market research report available in single user pdf license with Aarkstore Enterprise at USD 4950
View Report2020 Infectious Disease Testing: US, Europe, Japan--A Rapidly Growing and Challenging Market--Supplier Shares and Segment Forecasts for 100 Tests--Technological Breakthroughs, Emerging Tests, Competitive Analysis
This new report is a seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in
View ReportGlobal AI-Enabled Drug Discovery and Clinical Trials Market by Component (Solutions and Services), By Solution (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases, Immunologic Diseases, Infectious Diseases and Others), By End-User(Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast to 2020 to 2027
Global AI-Enabled Drug Discovery and Clinical Trials Market by Component (Solutions and Services), By Solution (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research and Others), By Therapeutic Applications (Oncology, Cardiovascular Diseases, Nervous System Diseases, Respiratory Disorder, Metabolic Diseases, Immunologic Diseases, Infectious Diseases and Others), By End-User(Biopharmaceutical Industry, Contract Research Organizations (CROs), and Academic Institutes and Research Centers), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast to 2020 to 2027 market research report available in single user pdf license with Aarkstore Enterprise at USD 4950
View Report2020 Infectious Disease Testing: US, Europe, Japan--A Rapidly Growing and Challenging Market--Supplier Shares and Segment Forecasts for 100 Tests--Technological Breakthroughs, Emerging Tests, Competitive Analysis
This new report is a seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in
View ReportFill The Form For Sample Request